Photo of { Yael Haberman Ziv, MD, PhD}

Yael Haberman Ziv, MD, PhD


  • Associate Professor, UC Department of Pediatrics

About

PhD: Tel-Aviv University, Tel-Aviv, Israel, 2006

MD: Tel-Aviv University, Tel-Aviv, Israel, 2007

Residency: Pediatrics, Sheba Medical Center, Tel-Hashomer, Israel, 2011

Fellowship: Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2014

Publications

An inflammasome-driven differentiation program in intestinal stem cells protects against Salmonella infection. Lebon, S; Habshush Menachem, A; Davidzohn, N; Katz, A; Wigoda, N; Braun, T; Yahalomi, D; Rotkopf, R; Holiar, V; Dadosh, T; Levin, Y; Haberman, Y; Hofree, M; Biton, M. Nature Immunology. 2026.

Perturbations of Diet and Gut Signatures Persist During Remission in Crohn's Disease Despite Effective Immune Suppression. Braun, T; Levhar, N; Efroni, G; Hadar, R; Levy, DJ; Talan Asher, A; Abu-Saad, K; Ziv, A; Ben-Avraham Shulman, S; Yahalom, A; Eliakim, R; Amir, A; Ben-Horin, S; Haberman, Y. Gastroenterology. 2026; 170(5):971-984.

Tu1488 SIMPLE SHORT-TERM NUT SUPPLEMENTATION INDUCED BENEFICIAL SHIFTS IN THE FECAL METABOLITE AND MICROBIAL PROFILES IN INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS. Dov, AB; Efroni, G; Levhar, N; Hadar, R; Levy, DJ; Talan-Asher, A; Heiman, S; Krauthammer, A; Berger, T; Loberman-Nachum, N; Granot, M; Vais, B; Ben-Horin, S; Amir, A; Haberman, Y. Gastroenterology. 2026; 170(6):s-1266-s-1267.

Sa1763 THE GUT MICROBIOME AS A REPORTER OF HEALTHY DIET, LIFESTYLE, FITNESS, AND OVERALL HEALTH. Haberman, Y; Braun, T; Haaronian, O; Hadar, R; Efroni, G; Ziv, R; Fenesh, M; Abbas-Egabriya, H; Amir, A. Gastroenterology. 2026; 170(6):s-2021-s-2022.

827 PERTURBATIONS OF DIET AND GUT SIGNATURES PERSIST DURING REMISSION IN CROHN’S DISEASE DESPITE EFFECTIVE IMMUNE SUPPRESSION. Haberman, Y; Braun, T; Levhar, N; Efroni, G; Hadar, R; Jessulalevy, D; Asher, AT; Ungar, B; Picard, O; Yablecovitch, D; Kopylov, U; Eliakim, R; Amir, A; Ben-Horin, S. Gastroenterology. 2026; 170(6):s-900-s-901.

Tu1488 SIMPLE SHORT-TERM NUT SUPPLEMENTATION INDUCED BENEFICIAL SHIFTS IN THE FECAL METABOLITE AND MICROBIAL PROFILES IN INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS. Dov, AB; Efroni, G; Levhar, N; Hadar, R; Levy, DJ; Talan-Asher, A; Heiman, S; Krauthammer, A; Berger, T; Loberman-Nachum, N; Granot, M; Vais, B; Ben-Horin, S; Amir, A; Haberman, Y. Gastrointestinal Endoscopy. 2026; 103(5):s-1266-s-1267.

Sa1763 THE GUT MICROBIOME AS A REPORTER OF HEALTHY DIET, LIFESTYLE, FITNESS, AND OVERALL HEALTH. Haberman, Y; Braun, T; Haaronian, O; Hadar, R; Efroni, G; Ziv, R; Fenesh, M; Abbas-Egabriya, H; Amir, A. Gastrointestinal Endoscopy. 2026; 103(5):s-2021-s-2022.

Sa1452 META ANALYSES OF GUT METABOLOMICS SIGNALS ACROSS FOUR IBD COHORTS HIGHLIGHT ROBUST, CONSISTENT SIGNALS, PRIORITIZING AZELATE AS A POTENTIAL BENEFICIAL INTERVENTION WITH FUNCTIONAL SUPPORT OF ITS ABILITY TO REDUCE EPITHELIAL INFLAMMATORY RESPONSE IN VITRO. Naamneh, R; Levhar, N; Braun, T; Efroni, G; Levy, DJ; Dov, AB; Ben-Horin, S; Amir, A; Haberman, Y. Gastrointestinal Endoscopy. 2026; 103(5):s-937.

Sa1452 META ANALYSES OF GUT METABOLOMICS SIGNALS ACROSS FOUR IBD COHORTS HIGHLIGHT ROBUST, CONSISTENT SIGNALS, PRIORITIZING AZELATE AS A POTENTIAL BENEFICIAL INTERVENTION WITH FUNCTIONAL SUPPORT OF ITS ABILITY TO REDUCE EPITHELIAL INFLAMMATORY RESPONSE IN VITRO. Naamneh, R; Levhar, N; Braun, T; Efroni, G; Levy, DJ; Dov, AB; Ben-Horin, S; Amir, A; Haberman, Y. Gastroenterology. 2026; 170(6):s-937.

827 PERTURBATIONS OF DIET AND GUT SIGNATURES PERSIST DURING REMISSION IN CROHN’S DISEASE DESPITE EFFECTIVE IMMUNE SUPPRESSION. Haberman, Y; Braun, T; Levhar, N; Efroni, G; Hadar, R; Jessulalevy, D; Asher, AT; Ungar, B; Picard, O; Yablecovitch, D; Kopylov, U; Eliakim, R; Amir, A; Ben-Horin, S. Gastrointestinal Endoscopy. 2026; 103(5):s-900-s-901.